JYNNEOS 50000000 1/.5mL
Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Bavarian Nordic A/S
JYNNEOS is a injection, powder, lyophilized, for suspension containing vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen at 50000000 1/.5mL, taken subcutaneous. Manufactured by Bavarian Nordic A/S.
Key Facts
- Brand Name
- JYNNEOS
- Generic Name
- Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen
- NDC Code (Product)
50632-002- Manufacturer
- Bavarian Nordic A/S
- Strength
- 50000000 1/.5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125678
- Marketing Start
- 04/14/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is JYNNEOS used for?
JYNNEOS contains Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen. It is a injection, powder, lyophilized, for suspension taken subcutaneous. Consult your doctor for specific uses.
Is JYNNEOS a controlled substance?
JYNNEOS is not classified as a controlled substance by the DEA.
What is the generic name for JYNNEOS?
The generic name for JYNNEOS is Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen. There are no other listed brand versions of Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen.
What is the NDC code for JYNNEOS 50000000 1/.5mL?
The NDC (National Drug Code) for JYNNEOS 50000000 1/.5mL is 50632-002, listed by Bavarian Nordic A/S.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)